insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,44 USD
arrow_downward
-3,30%(-0,15) 1D
18-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 USD
High
4,60 USD
Low
4,41 USD
Mkt. cap
61,82 млн
Avg. vol.
7,41 миң
Volume
11,73 миң
52-wk high
8,31 USD
52-wk low
4,41 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,55 USD
High
4,60 USD
Low
4,41 USD
Mkt. cap
61,82 млн
Avg. vol.
7,41 миң
Volume
11,73 миң
52-wk high
8,31 USD
52-wk low
4,41 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 саат мурун
S&P 500 Postmarket Gainers: PANW, CRWD and OKTA Extend After-Hours Gains
FXStreet
·
50 мүнөт мурун
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
The Motley Fool
·
29 мүнөт мурун
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Traders Union
·
1 саат мурун
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com